Related Experiment Video

Updated: Mar 17, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

14.0K

Drug discovery in advanced prostate cancer: translating biology into therapy

Timothy A Yap1,2, Alan D Smith1,2, Roberta Ferraldeschi1,2

  • 1The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, UK.

Nature Reviews. Drug Discovery
|July 23, 2016
PubMed

Insights

Advances in understanding prostate cancer biology offer new therapeutic targets for castration-resistant prostate cancer (CRPC). This review covers novel drug discovery, precision medicine, and immunotherapy challenges for CRPC management.

Area of Science:

  • Oncology
  • Genetics
  • Pharmacology

Background:

  • Castration-resistant prostate cancer (CRPC) presents significant therapeutic challenges and a poor prognosis.
  • Recent genetic and technological advancements offer new insights into prostate cancer biology.
  • Identification of novel drug targets and molecularly targeted therapeutics is crucial for CRPC treatment.

Purpose of the Study:

  • To review recent advances in prostate cancer target identification for drug discovery.
  • To discuss the promise and challenges of novel therapeutics for CRPC.
  • To explore the evolving therapeutic landscape, including precision medicine and immunotherapy for CRPC.

Main Methods:

  • Literature review of recent advances in prostate cancer research.
  • Analysis of genetic and technological breakthroughs in drug discovery.
  • Discussion of clinical and translational challenges in CRPC treatment.

Main Results:

  • Novel drug targets and molecularly targeted therapeutics have been identified for CRPC.
  • Progress in understanding prostate cancer biology informs new therapeutic strategies.
  • Challenges remain in precision medicine and immunotherapy for CRPC.

Conclusions:

  • Future management of CRPC will likely involve a combination of targeted therapies, immunotherapy, and precision medicine.
  • Circulating biomarkers and innovative clinical trial designs are key to advancing CRPC treatment.
  • Continued research into prostate cancer biology is essential for developing more effective therapies.

More Related Videos

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses08:36

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses

Published on: October 24, 2019

11.8K
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

15.3K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
73